MoneyWorks4Me

Ind-Swift Laboratories informs about cessation of independent director

25 Mar 2021 Evaluate

Pursuant to the provisions of Regulation 30 and any other applicable provisions, if any, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ind-Swift Laboratories has informed that Prabhat Khurana (DIN: 03289193) who was appointed as an Independent Director for a term of five years from 25th March, 2016 to 24th March, 2021 has ceased to be an Independent Director of the Company with effect from the close of business hours of March 24, 2021 consequent to the completion of his term of appointment.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..